Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression

Song He1, Dechun Zhang, Fang Cheng

  • 1Molecular Medicine & Tumor Research Center, Chongqing Medical University, Chongqing, China. jarm190@163.com

Insights

Gene therapy using RNA interference (RNAi) offers a potent method for gene silencing in cancer research. Small interfering RNA (siRNA) targets complementary mRNA, showing promise for novel cancer therapeutics and clinical treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Cancer presents a significant global therapeutic challenge, necessitating the development of innovative treatments.
  • Gene therapy, a form of molecular medicine, introduces genetic material into target cells for therapeutic purposes.
  • RNA interference (RNAi) has emerged as a powerful gene silencing technique with broad applications in biological research.

Purpose of the Study:

  • To explore the potential of RNA interference (RNAi) as a novel therapeutic strategy for cancer treatment.
  • To highlight the mechanism of RNAi in gene silencing for fundamental cancer research.
  • To assess the clinical applicability of RNAi-based cancer therapies.

Main Methods:

  • Utilizing small interfering RNA (siRNA) duplexes to target and silence specific genes.
  • Investigating the post-transcriptional gene silencing process mediated by RNA interference.
  • Analyzing the efficacy of RNAi in preclinical cancer models and its potential for clinical translation.

Main Results:

  • RNA interference effectively silences gene expression by degrading target messenger RNA (mRNA).
  • siRNA-mediated gene silencing has demonstrated significant potential in fundamental cancer research.
  • The application of RNAi in cancer therapeutics shows promising results for clinical treatment.

Conclusions:

  • RNA interference is a potent and rapidly developing gene silencing tool with substantial importance in genetics and molecular biology.
  • RNAi-based gene therapy represents a promising modality for addressing the therapeutic challenges posed by cancer.
  • Further research and clinical application of RNAi hold great potential for advancing cancer treatment strategies.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...